Arm Lymphedema After Breast Cancer
Conditions
Keywords
compression bandage, manual lymphatic drainage, lymphedema, breast cancer, qualitative research.
Brief summary
Lymphedema is the result of accumulation of fluid and other elements in tissue spaces because of an imbalance between the production of fluid interstitial and transport. Lymphedema can cause significant physical and psychological morbidity. Prevalence of lymphedema in patients after breast cancer surgery is 12-60% and the incidence is 12-26%.Psychological and social consequences of secondary lymphedema related breast cancer have been little recognized and documented. Although, it have performed many studies related secondary lymphedema it not found sufficient evidence in the literature to suggest the most effective treatment. There is some evidence suggesting that compression therapy and manual lymphatic drainage can improve lymphedema but more studies are needed. The aim of this research is to to evaluate the clinical effect of multimodal treatment (compression bandaging and manual lymph drainage) versus applying manual lymphatic drainage in women with arm lymphedema after breast cancer surgery.
Detailed description
This study has two sub research: a quantitative approach and a qualitative approach. The research will be carried out by a multicenter way Quantitative approach consist in carried out a single-blind randomized controlled trial of 44 women with arm lymphedema. Patients will be distributed in two intervention groups by a randomized way. Participants will be given his assignment by closed envelope. Both treatments will be administered five days a week for six weeks. The experimental group (n=22) will receive multimodal treatment: combination of manual lymphatic drainage and compression bandaging. The control group (n=22) only will receive manual lymphatic drainage. We want to determinate the effect on volume arm decrease, quality of life, level of hand strength, degree of pain, fatigue level, and state of anxiety and depression. The influence on the lymphedema will be analyzed with lower limbs strength, physical activity, lung function, respiratory muscle strength by maximal inspiratory and expiratory pressure measurements (MIP and MEP) and cardiorespiratory functional capacity. Patients adherence will be analyzed by a smartphone. Qualitative apprach: to know the perceptions and experiences of the participants in both interventions groups through a qualitative descriptive study. Data will be obtained with semi-structured depth interview.
Interventions
OTHERMultimodal treatment: compression bandaging and manual lymph drainage.
30 minutes and one hour maximum time of manual lymphatic drainage and compression bandaging with multilayer inelastic bandages with low extensibility. It is possible to apply bandages two or three times per week. Also, an elastic bandage is also held in hand fingers with slight compression and other protective bandage is used in skin. The treatment will be carried out for six weeks five days a week
30 minutes and one hour maximum time of manual lymphatic drainage. The treatment will be carried out for six weeks five days a week.
Sponsors
University of Malaga
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
FEMALE
Age
45 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Women between 45 and 65 years with secondary lymphedema in upper limb after breast cancer surgery. * Cancer stages I-III according to TNM classification of the American Joint Committee on Cancer.
Exclusion criteria
* To have received lymphedema treatment previously. * To be treated by radiation therapy or chemotherapy. * Distant metastases or local recurrence of cancer. * Infectious signs in the upper limb with lymphedema. * Uncontrolled hypertension. * Heart disease.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Perimetry | Baseline, 6 weeks and 12 weeks | Arm volume is measured with perimetry through truncation of cones formula |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Multiple sit-to-stant test | Baseline, 6 weeks and 12 weeks | Multiple sit-to-stant test will be used to evaluate lower limbs strength. |
| Degree of pain | Baseline, 6 weeks and 12 weeks | The degree of pain in the affected side with lymphedema will be measured by digital algometer Commander ™ |
| Pulmonary function test | Baseline, 6 weeks and 12 weeks | Simple spirometry to measure lung function with a spirometer DATOSPIR120 |
| Maximal inspiratory pressures (MIP) and maximal expiratory pressures (MEP) | Baseline, 6 weeks and 12 weeks | The strength of the respiratory muscles is measured through a digital manovacuometer (DATOSPIR120) |
| Six-minute walking test | Baseline, 6 weeks and 12 weeks | Cardiorespiratory functional capacity as measured with six-minute walking test. |
| FACT-B+4 questionnaire | Baseline, 6 weeks and 12 weeks | FACT-B+4 questionnaire to measure quality of life in patients with breast cancer and lymphedema. Alpha of cronbach: 0,52-0,92 |
| Handgrip strength | Baseline, 6 weeks and 12 weeks | Handgrip strength will be determined using hydraulic hand dynamometer JAMAR |
| QLQ BR23 questionnaire | Baseline, 6 weeks and 12 weeks | QLQ BR23 questionnaire to know quality of life in patients with breast cancer. Alpha of cronbach: 0,48 y 0,94 |
| HADS questionnaire | Baseline, 6 weeks and 12 weeks | HADS questionnaire to measure depression and anxiety. Alpha of cronbach: 0´8-0´76 |
| QuickPIPPER questionnaire | Baseline, 6 weeks and 12 weeks | QuickPIPPER questionnaire measures the level of fatigue in breast cancer. Alpha of cronbach: 0,730- 0,961 |
| The short version of the IPAQ | Baseline, 6 weeks and 12 weeks | The short version of the IPAQ questionnaire for physical activity level. Alpha of cronbach: 0,75 |
| Qualitative measures | 6 weeks | Data collection was carried out through an interview in-depth semi-structured. The dimensions of the study were developed based on bibliography and objectives of the study: perceptions and experiences with multimodal treatment, ways of living with lymphedema, life style, Physical activity and exercise. |
| Smartphone-based application | Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks | Smartphone-based application to analyze the treatment adherence of the participants |
| EORTIC-QLQ-C30 questionnaire | Baseline, 6 weeks and 12 weeks | EORTIC-QLQ-C30 questionnaire measures the quality of life in cancer. Alpha of cronbach: 0,52 y 0,89 |
Countries
Spain
Contacts
Primary ContactMartín-Valero R., Ph D
Outcome results
None listed